Researchers corrected lamin A gene mutations, preventing skeletal and cardiac abnormalities and extending mice lifespans.
GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-TKI, a novel multi-receptor tyrosine kinase inhibitor for cancer immunotherapy. GNTbm-TKI will be presented as posters at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback